We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cassava is advancing simufilam through a pivotal phase 3 trial, despite lingering controversy from a SEC investigation. As the company prepares to release trial results, Ben Hargreaves finds that ...

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 ...

SLS SELLAS Life Sciences Group, Inc.

The 10 semifinalists have been announced in the 2025 international ‘Wege Prize’ design competition where college and ...

And while evidence shows these synthetic particulates aren’t great for you, the medical community still isn’t entirely sure how the plastic specifically affects health, as well as its ...

smallest challenges posed by rampant plastic pollution. That is the leaking microplastics that are increasingly finding their way deep into the ocean, in remote land features like Mount Everest, in ...